CEO Resignation Novo Nordisk - Search News

Order byBest matchMost fresh

News

Novo Nordisk ousts CEO

Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S (NYSE:NVO) abruptly announced the resignation of veteran CEO Lars Fruergaard Jørgensenm last week.

Continue reading

· 4h · on MSN

· 4d · on MSN

Novo Nordisk ousts CEO after falling behind in weight loss market

· 1d · on MSN

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

4don MSN

Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year

CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for ...

4d

Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition

The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results